By continuing to use this site you consent to the use of cookies on your device as described in our
Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.

"The complaint alleges that Dr Reddy's US subsidiary and the other named defendants engaged in a conspiracy to fix prices and to allocate bids and customers in the United States in the sale of the drugs," the company said.

It further said, "Currently, we do not foresee any material impact to our operations and consolidated results with respect to this matter."

The company said its US subsidiary is specifically named as a defendant with respect to five generic drugs (Ciprofloxacin HCL tablets, Glimepiride tablets, Oxaprozin tablets, Paricalcitol and Tizanidine), for an alleged "overarching conspiracy".

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)